News brief covers ISMP’s alert warning pharmacists about potential error risks with Paxlovid, a COVID-antivral regimen, highlighting that patients with moderate renal impairment should receive a dose reduction.
For the full text, visit Becker’s Hospital Review online.
More News
ECRI’s report warns of potential safety risks with 10 health technologies, including single-use products, medication cabinets, cybersecurity of cloud-based systems, and ventilator disinfection
I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.
This article appeared on the Pharmacy Practice News website on December 15, 2022